Product Description
Since last manyyears Saintroy Lifescience is leading manufacture, export and supplierofIdarubicin Hydrochloride for Injectionfrom Surat, Gujarat, India. Idarubicin Hydrochloride for Injection used for treatment of acute lymphoblastic leukemia and chronic myelogenous leukemia in blast crisis.
Tags: Idarubicin Hydrochloride for Injection manufacturer, Idarubicin Hydrochloridefor Injection exporter, Idarubicin Hydrochloride for Injection supplier,and Idarubicin Hydrochloride for Injection, whogmp approved Idarubicin Hydrochloridefor Injection manufacturer and supplier, Idarubicin Hydrochloride ForInjection distributor, Idarubicin Hydrochloride for Injection shipper, Idarubicin Hydrochloridefor Injection 10 ml Idarubicin Hydrochloride for Injection 10 ml supplier,Idarubicin Hydrochloride for Injection 10 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing
facility in Gujarat, India.
Registration: Saintroy Lifescience is interested in registrationof own brand or customer brands in ministry of health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country :Saintroy Lifescience Idarubicin Hydrochloridefor Injection export to USA, Canada, Germany, Europe, France,Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon,Peru, Chile, Somalia, Philippines, Myanmar, Maldives, Thailand, Singapore,Malaysia, Hong Kong, China, Zimbabwe, Togo, Burkina Faso, Niger,Guinea Bissau,Congo, Democratic of republic, Ivory Costa, Oman, Guatemala, Nicaragua,Salvador, Qatar, Costa Rica, Panama, Cuba, Colombia, Bolivia, Argentine,Algeria, Guyana, Morocco, Jordan, Bahrain, Iran, Egypt, Kyrgyzstan, Uzbekistan,Kazakhstan.
Effective Treatment for Hematological MalignanciesIdarubicin Hydrochloride for Injection is highly regarded for its efficacy in treating acute myeloid leukemia and other hematologic cancers. By interfering with cancer cell DNA synthesis, it helps in reducing malignant cell populations, thereby providing critical therapeutic benefit to patients battling these diseases.
Safe and Secure PackagingEach vial comes in glass packaging with a flip-off cap, ensuring safety and product integrity. The latex-free materials minimize the risk of allergic reactions, and the single-use design prevents cross-contamination, emphasizing patient safety and compliance with medical standards.
Strict Storage and Disposal GuidelinesThis medication should be stored in a cool, dry place and used immediately once reconstituted. As a cytotoxic drug, all unused product and waste must be discarded according to local hazardous waste protocols to ensure environmental and occupational safety.
FAQ's of Idarubicin Hydrochloride for Injection:
Q: How should Idarubicin Hydrochloride for Injection be prepared and administered?
A: Firstly, reconstitute the lyophilized powder with the specified volume of Sterile Water for Injection according to instructions. It should be administered only via intravenous injection by medical professionals. Do not mix with other drugs in the same syringe or infusion bag.
Q: What conditions is this medication indicated for?
A: Idarubicin Hydrochloride for Injection is mainly indicated for the treatment of acute myeloid leukemia (AML) and may also be used in certain other hematologic malignancies as prescribed by a healthcare provider.
Q: When should the reconstituted solution be used and how should it be stored?
A: After reconstitution, the solution should be used promptly. If storage is necessary, follow the specific time and temperature guidelines provided in the product insert. Generally, it should be stored in a cool, dry place to maintain its stability.
Q: Where can hospitals and clinics purchase this product in India?
A: Dealers, distributors, exporters, manufacturers, suppliers, traders, and wholesalers across India supply Idarubicin Hydrochloride for Injection. Institutions should ensure procurement from licensed pharmaceutical sources to guarantee authenticity and compliance with standards.
Q: What benefits does lyophilization offer for this medication?
A: Lyophilization, or freeze-drying, maintains the stability and potency of Idarubicin Hydrochloride for Injection during transport and storage. It also allows for easy reconstitution when needed, ensuring consistent therapeutic efficacy.
Q: What precautions should be followed when handling this product?
A: As a cytotoxic drug, Idarubicin Hydrochloride for Injection must be handled with care, using gloves and protective equipment. Disposal of unused medication and materials should conform to local regulations to minimize health and environmental hazards.
Q: What should I know about compatibility with other drugs?
A: This medication should not be mixed with other drugs in the same syringe or infusion fluid to avoid incompatibility or harmful reactions. Always follow your healthcare provider's instructions regarding administration.